Skip to main content

Advertisement

Log in

Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report

  • CASE REPORT
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

 We encountered a 44-year-old woman with acute eosinophilic myocarditis that showed positive immunostaining for interleukin-4 in the area of marked infiltration of eosinophils into the myocardium. When prednisolone alone proved ineffective, supplementary treatment with suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, improved the patient's inflammation, reduced the level of cardiac enzymes, and allowed for a reduction in corticosteroid dosage without any adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: July 10, 2002 / Accepted: October 6, 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umemoto, S., Itagaki, K., Kimura, M. et al. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report. Heart Vessels 18, 100–102 (2003). https://doi.org/10.1007/s10380-002-0689-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10380-002-0689-2

Navigation